The alteration frequency of ELAVL2 in various cancer datasets was ranked, and the result showed that ELAVL2 was deleted at the highest level in GBM compared to other cancers, suggesting that ELAVL2 deletion is one of the frequent genomic alterations in GBM (Fig. 1c). The gene discussed is ELAVL2; the disease is cancer.